Article

Translating a Pathology Report

It is important to have a copy of your pathology report so you have documentation of your diagnosis

By law, patients are entitled to a copy of their path­ology report, and most hospitals will provide a copy free of charge. It’s important to get a copy of the pathology report to have documentation of the diagnosis; this information will be helpful in researching the disease.

Below is a brief explanation of information found in a pathology report.

Demographics: Includes information about the patient, such as the patient’s name, age, sex and date of procedure.

Specimen: Describes the origin of the tissue samples.

Clinical history: Details the patient's medical history, covering topics such as how the patient's cancer was found.

Clinical diagnosis: Indicates the diagnosis doctors were expecting before the patient's tissue was tested.

Procedure: Explains how the tissue sample was removed.

Gross description: Details the tissue sample(s), including the size, weight and color of each sample.

Microscopic description: Describes the way the cancer cells look under the microscope and may identify tumor characteristics, including grade, tumor margins and pathologic stage.

Special tests or markers: Reports the results of tests that look for proteins, genes and how quickly the cells are growing. These findings are often contained in a separate report.

Summary: Gives a pathologic diagnosis based on the information from the entire pathology report.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Waldenstrom macroglobulinemia is often slow growing, with high survival but lower quality of life over time, explained researcher Alisha Kimble.
Image of woman.
Image of two doctors and text.
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
image of serzan.
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Image of two doctors with text.
Image of doctors with text.
Imiage of two doctors with text.
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
Related Content